Renaissance Group Llc
Source: SEC Form 13F · as of Mar 2026Renaissance Group Llc holds 18 biotech & pharma companies tracked by BioSniper, totaling $298.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$298.3M
| Company | Shares | Value |
|---|---|---|
| CAHCardinal Health Inc. | 174,115 | $36.8M |
| ABBVAbbVie Inc. | 153,106 | $33.3M |
| NBIXNEUROCRINE BIOSCIENCES INC | 246,377 | $32.5M |
| AMGNAMGEN INC | 92,224 | $32.4M |
| MCKMcKesson Corporation | 37,488 | $32.4M |
| ZTSZoetis Inc. | 271,958 | $32.1M |
| HALOHALOZYME THERAPEUTICS, INC. | 471,499 | $30.5M |
| MEDPMedpace Holdings Inc. | 24,494 | $11.8M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 445,215 | $11.0M |
| JAZZJazz Pharmaceuticals plc | 51,168 | $9.7M |
| TEVATeva Pharmaceutical Industries Limited | 283,621 | $8.5M |
| MMSIMerit Medical Systems Inc. | 122,551 | $8.4M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 116,633 | $6.4M |
| ADMAADMA BIOLOGICS, INC. | 642,535 | $5.8M |
| SNYSanofi | 92,456 | $4.5M |
| KMDAKAMADA LTD | 125,901 | $1.1M |
| CORCencora Inc. | 1,842 | $579K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,072 | $479K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.